One Nucleus announces new director

Industry expert to support life sciences membership group

One Nucleus, a membership company for international life science and healthcare companies based in Cambridge and London in the UK, has appointed Dr Alan Palmer as a director. Palmer is co-founder and currently chief scientific officer at MS Therapeutics and has 30 years’ experience in the biotechnology sector in roles spanning academia, research and industry.

Palmer has close ties with the London life science and healthcare community and was a strong supporter of the London Biotechnology Network (LBN), which is now part of One Nucleus.

Commenting on his appointment, Palmer said: “I have worked with Harriet Fear and Tony Jones for many years and am very excited about the merger of ERBI and LBN to form One Nucleus. These are challenging times and One Nucleus is extremely well placed to support the biotechnology sector.’

Harriet Fear, ceo of One Nucleus, added: ‘Alan is a great addition to the team. He has a deep understanding of the needs of One Nucleus members, and this coupled with his academic and pharma background makes him an ideal director for One Nucleus.’

You may also like

Media
Siemens named Leader in IDC MarketScape assessment of life sciences R&D technology

Siemens named Leader in IDC MarketScape assessment of life sciences R&D technology

The company has been recognised for its end-to-end digital capabilities, AI-enabled portfolio and open Smart Lab Ecosystem in IDC’s 2026 assessment of life sciences R&D technology providers, with case studies from GSK and AstraZeneca highlighting the potential of digital twins and process modelling to accelerate development and manufacturing
Media
Vetter wins Red Dot Award for next-generation syringe closure

Vetter wins Red Dot Award for next-generation syringe closure

The firm's V-OVS next syringe closure system has received a Red Dot Design Concept Award, recognising design features intended to improve handling, product integrity and user experience for injectable medicines
Media
Guardtech gearing up for an action-packed 2026 exhibition finale

Guardtech gearing up for an action-packed 2026 exhibition finale

The contamination control specialists prepare for a busy autumn schedule across Healthcare, Pharmaceutical and Biotechnology events
Media
Touchlight wins CPHI Pharma Award for cell-free DNA manufacturing

Touchlight wins CPHI Pharma Award for cell-free DNA manufacturing

The UK biotech's Doggybone DNA platform won the Innovation Catalyst category at CPHI Milan 2026, recognising its potential to support scalable DNA production for genetic medicines
Media
CPHI Pharma Awards 2026 recognise Touchlight, SeraNovo and Almac among fifteen category winners in Milan

CPHI Pharma Awards 2026 recognise Touchlight, SeraNovo and Almac among fifteen category winners in Milan

Touchlight's dbDNA platform took Innovation Catalyst, SeraNovo's NanoGlass oral formulation won Finished Formulation and Almac Clinical Services claimed Supply Chain Excellence — with BMS's Emma Charles named Woman of the Year
Media
CPHI Milan's inaugural Sustainability Summit brings 300+ companies together to tackle pharma's sustainability challenges

CPHI Milan's inaugural Sustainability Summit brings 300+ companies together to tackle pharma's sustainability challenges

The two-day programme addresses practical barriers to sustainable procurement, manufacturing and packaging — with hackathon-style sessions and cross-industry collaboration designed to move beyond targets into measurable operational action
Media
FUJIFILM Biotechnologies lands three CPHI Pharma Award nominations for continuous manufacturing and precision purification

FUJIFILM Biotechnologies lands three CPHI Pharma Award nominations for continuous manufacturing and precision purification

The CDMO's MaruX platform, ShunzymeX purification technology and COO Maja Pedersen are all shortlisted ahead of its CPHI Milan appearance at booth 8A2, where senior leadership will present on Europe's biomanufacturing strategy
Subscribe now